Provided by Tiger Trade Technology Pte. Ltd.

ArriVent BioPharma

31.14
-0.2100-0.67%
Post-market: 31.140.00000.00%19:30 EDT
Volume:433.84K
Turnover:13.48M
Market Cap:1.54B
PE:-8.42
High:31.41
Open:31.21
Low:30.11
Close:31.35
52wk High:35.83
52wk Low:17.00
Shares:49.31M
Float Shares:32.11M
Volume Ratio:0.90
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6975
EPS(LYR):-4.3239
ROE:-53.25%
ROA:-33.11%
PB:4.19
PE(LYR):-7.20

Loading ...

U.S. RESEARCH ROUNDUP-Elevance Health, Huntington Bancshares, Monolithic Power Systems

Reuters
·
Apr 24

JonesTrading Remains a Buy on ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Apr 07

ArriVent BioPharma Is Maintained at Buy by B. Riley Securities

Dow Jones
·
Mar 24

ArriVent Biopharma price target raised to $45 from $37 at B. Riley

TIPRANKS
·
Mar 23

B. Riley Adjusts ArriVent BioPharma Price Target to $45 From $37, Maintains Buy Rating

MT Newswires Live
·
Mar 23

U.S. RESEARCH ROUNDUP- ArriVent Biopharma, Aveanna Healthcare Holdings, EQT

Reuters
·
Mar 23

Arrivent Biopharma Inc : B. Riley Raises Target Price to $45 From $37

THOMSON REUTERS
·
Mar 23

Is ArriVent BioPharma (AVBP) Offering Value After Recent Share Price Pullback?

Simply Wall St.
·
Mar 20

ArriVent Highlights Next-Generation Oncology Data at AACR 2026

TIPRANKS
·
Mar 18

ArriVent BioPharma Coverage Assumed by BTIG at Buy

Dow Jones
·
Mar 12

U.S. RESEARCH ROUNDUP-AeroVironment, Bumble, Lumentum.

Reuters
·
Mar 12

Arrivent Biopharma Inc : Btig Assumes Coverage With Buy Rating; Price Target $42

THOMSON REUTERS
·
Mar 12

ArriVent Biopharma assumed with a Buy at BTIG

TIPRANKS
·
Mar 12

Stock Track | ArriVent BioPharma Soars 6.40% Intraday on Analyst Bullishness

Stock Track
·
Mar 09

Oppenheimer Adjusts Price Target on ArriVent BioPharma to $50 From $44, Maintains Outperform Rating

MT Newswires Live
·
Mar 06

Arrivent Biopharma, Inc. : Oppenheimer Raises Target Price to $50 From $44

THOMSON REUTERS
·
Mar 06

ArriVent BioPharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 06

Guggenheim Sticks to Their Buy Rating for ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Mar 06

ArriVent Biopharma price target raised to $33 from $31 at Citi

TIPRANKS
·
Mar 06

ArriVent BioPharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 06